BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kolilekas L, Manali E, Vlami KA, Lyberopoulos P, Triantafillidou C, Kagouridis K, Baou K, Gyftopoulos S, Vougas KN, Karakatsani A. Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis. J Clin Sleep Med. 2013;9:593-601. [PMID: 23772193 DOI: 10.5664/jcsm.2758] [Cited by in Crossref: 78] [Cited by in F6Publishing: 65] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Jo HE, Troy LK, Keir G, Chambers DC, Holland A, Goh N, Wilsher M, de Boer S, Moodley Y, Grainge C, Whitford H, Chapman S, Reynolds PN, Glaspole I, Beatson D, Jones L, Hopkins P, Corte TJ. Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia: Treatment of IPF. Respirology 2017;22:1436-58. [DOI: 10.1111/resp.13146] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
2 Jo HE, Prasad JD, Troy LK, Mahar A, Bleasel J, Ellis SJ, Chambers DC, Holland AE, Lake FR, Keir G, Goh NS, Wilsher M, de Boer S, Moodley Y, Grainge C, Whitford HM, Chapman SA, Reynolds PN, Beatson D, Jones LJ, Hopkins P, Allan HM, Glaspole I, Corte TJ. Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary. Med J Aust 2018;208:82-8. [PMID: 29385965 DOI: 10.5694/mja17.00799] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
3 Lee JH, Park CS, Song JW. Obstructive sleep apnea in patients with interstitial lung disease: Prevalence and predictive factors. PLoS One 2020;15:e0239963. [PMID: 33017401 DOI: 10.1371/journal.pone.0239963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Faverio P, De Giacomi F, Bonaiti G, Stainer A, Sardella L, Pellegrino G, Sferrazza Papa GF, Bini F, Bodini BD, Carone M, Annoni S, Messinesi G, Pesci A. Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights. Int J Med Sci 2019;16:967-80. [PMID: 31341410 DOI: 10.7150/ijms.32752] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 van Jaarsveld MF, Gwyther L. A systematic review of literature to evaluate the burden of physical and psychological symptoms and palliative care in patients diagnosed with idiopathic pulmonary fibrosis. Afr J Thorac Crit Care Med 2019;25. [PMID: 34286243 DOI: 10.7196/AJTCCM.2019.v25i1.231] [Reference Citation Analysis]
6 Mermigkis C, Bouloukaki I, Schiza SE. Sleep as a New Target for Improving Outcomes in Idiopathic Pulmonary Fibrosis. Chest 2017;152:1327-38. [PMID: 28774636 DOI: 10.1016/j.chest.2017.07.019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 6.4] [Reference Citation Analysis]
7 van Cleemput J, Sonaglioni A, Wuyts WA, Bengus M, Stauffer JL, Harari S. Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management. Adv Ther 2019;36:298-317. [PMID: 30554332 DOI: 10.1007/s12325-018-0857-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
8 Buendía-Roldán I, Mejía M, Navarro C, Selman M. Idiopathic pulmonary fibrosis: Clinical behavior and aging associated comorbidities. Respir Med 2017;129:46-52. [PMID: 28732835 DOI: 10.1016/j.rmed.2017.06.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
9 Schiza S, Mermigkis C, Margaritopoulos GA, Daniil Z, Harari S, Poletti V, Renzoni EA, Torre O, Visca D, Bouloukaki I, Sourvinos G, Antoniou KM. Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night. Eur Respir Rev 2015;24:327-39. [DOI: 10.1183/16000617.00009114] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
10 Li D, Wang B, Liu Y, Wang H. Prevalence and impact of comorbid obstructive sleep apnoea in diffuse parenchymal lung diseases. PLoS One 2021;16:e0246878. [PMID: 33571266 DOI: 10.1371/journal.pone.0246878] [Reference Citation Analysis]
11 Lee JH, Park CS, Song JW. Obstructive sleep apnea in patients with interstitial lung disease: Prevalence and predictive factors. PLoS One 2020;15:e0239963. [PMID: 33017401 DOI: 10.1371/journal.pone.0239963] [Reference Citation Analysis]
12 Ahluwalia N, Shea BS, Tager AM. New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses. Am J Respir Crit Care Med 2014;190:867-78. [PMID: 25090037 DOI: 10.1164/rccm.201403-0509PP] [Cited by in Crossref: 154] [Cited by in F6Publishing: 81] [Article Influence: 19.3] [Reference Citation Analysis]
13 Trachalaki A, Irfan M, Wells AU. Pharmacological management of Idiopathic Pulmonary Fibrosis: current and emerging options. Expert Opin Pharmacother 2021;22:191-204. [PMID: 32993388 DOI: 10.1080/14656566.2020.1822326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bosi M, Milioli G, Fanfulla F, Tomassetti S, Ryu JH, Parrino L, Riccardi S, Melpignano A, Vaudano AE, Ravaglia C, Tantalocco P, Rossi A, Poletti V. OSA and Prolonged Oxygen Desaturation During Sleep are Strong Predictors of Poor Outcome in IPF. Lung 2017;195:643-51. [PMID: 28674777 DOI: 10.1007/s00408-017-0031-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
15 Khor YH, Ng Y, Sweeney D, Ryerson CJ. Nocturnal hypoxaemia in interstitial lung disease: a systematic review. Thorax 2021:thoraxjnl-2020-216749. [PMID: 33927018 DOI: 10.1136/thoraxjnl-2020-216749] [Reference Citation Analysis]
16 Torrisi SE, Vancheri A, Pavone M, Sambataro G, Palmucci S, Vancheri C. Comorbidities of IPF: How do they impact on prognosis. Pulm Pharmacol Ther 2018;53:6-11. [PMID: 30193867 DOI: 10.1016/j.pupt.2018.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
17 Canora A, Nicoletta C, Ghinassi G, Bruzzese D, Rea G, Capaccio A, Castaldo S, Coppola A, Polistina GE, Sanduzzi A, Bocchino M. First Description of the Hyperpnea-Hypopnea Periodic Breathing in Patients with Interstitial Lung Disease-Obstructive Sleep Apnea: Treatment Implications in a Real-Life Setting. Int J Environ Res Public Health 2019;16:E4712. [PMID: 31779226 DOI: 10.3390/ijerph16234712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Caminati A, Lonati C, Cassandro R, Elia D, Pelosi G, Torre O, Zompatori M, Uslenghi E, Harari S. Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue. Eur Respir Rev 2019;28:190044. [PMID: 31578211 DOI: 10.1183/16000617.0044-2019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 9.7] [Reference Citation Analysis]
19 Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J 2015;46:1113-30. [DOI: 10.1183/13993003.02316-2014] [Cited by in Crossref: 188] [Cited by in F6Publishing: 169] [Article Influence: 26.9] [Reference Citation Analysis]
20 Margaritopoulos GA, Kokosi MA, Wells AU. Diagnosing complications and co-morbidities of fibrotic interstitial lung disease. Expert Rev Respir Med 2019;13:645-58. [PMID: 31215263 DOI: 10.1080/17476348.2019.1632196] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
21 Oldham JM, Collard HR. Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management. Front Med (Lausanne) 2017;4:123. [PMID: 28824912 DOI: 10.3389/fmed.2017.00123] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
22 Rai DK. Profile of sleep-disordered breathing in ILD: Could be better with study design? Lung India 2021;38:204-5. [PMID: 33687023 DOI: 10.4103/lungindia.lungindia_838_20] [Reference Citation Analysis]
23 Luppi F, Kalluri M, Faverio P, Kreuter M, Ferrara G. Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management. Respir Res 2021;22:109. [PMID: 33865386 DOI: 10.1186/s12931-021-01711-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Cade BE, Chen H, Stilp AM, Louie T, Ancoli-Israel S, Arens R, Barfield R, Below JE, Cai J, Conomos MP, Evans DS, Frazier-Wood AC, Gharib SA, Gleason KJ, Gottlieb DJ, Hillman DR, Johnson WC, Lederer DJ, Lee J, Loredo JS, Mei H, Mukherjee S, Patel SR, Post WS, Purcell SM, Ramos AR, Reid KJ, Rice K, Shah NA, Sofer T, Taylor KD, Thornton TA, Wang H, Yaffe K, Zee PC, Hanis CL, Palmer LJ, Rotter JI, Stone KL, Tranah GJ, Wilson JG, Sunyaev SR, Laurie CC, Zhu X, Saxena R, Lin X, Redline S. Associations of variants In the hexokinase 1 and interleukin 18 receptor regions with oxyhemoglobin saturation during sleep. PLoS Genet 2019;15:e1007739. [PMID: 30990817 DOI: 10.1371/journal.pgen.1007739] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
25 Jo HE, Randhawa S, Corte TJ, Moodley Y. Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations. Drugs Aging 2016;33:321-34. [PMID: 27083934 DOI: 10.1007/s40266-016-0366-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
26 de Boer K, Lee JS. Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review. Respirology 2016;21:995-1004. [PMID: 26365251 DOI: 10.1111/resp.12622] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Copeland CR, Lancaster LH. Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD). Front Med (Lausanne) 2021;8:743977. [PMID: 34722582 DOI: 10.3389/fmed.2021.743977] [Reference Citation Analysis]
28 Lee R, Kelly E, Nolan G, Eigenheer S, Boylan D, Murphy D, Dodd J, Keane M, Mcnicholas W. Disordered breathing during sleep and exercise in idiopathic pulmonary fibrosis and the role of biomarkers. QJM 2015;108:315-23. [DOI: 10.1093/qjmed/hcu175] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
29 Ryu JH, Moua T, Daniels CE, Hartman TE, Yi ES, Utz JP, Limper AH. Idiopathic Pulmonary Fibrosis: Evolving Concepts. Mayo Clinic Proceedings 2014;89:1130-42. [DOI: 10.1016/j.mayocp.2014.03.016] [Cited by in Crossref: 84] [Cited by in F6Publishing: 72] [Article Influence: 10.5] [Reference Citation Analysis]
30 Troy LK, Young IH, Lau EM, Wong KK, Yee BJ, Torzillo PJ, Corte TJ. Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease. Respirology 2019;24:996-1004. [DOI: 10.1111/resp.13549] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
31 Cardoso AV, Pereira N, Neves I, Santos V, Jesus JM, Melo N, Mota PC, Morais A, Drummond M. Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease-characterization and treatment compliance assessment. Can J Respir Ther 2018;54:35-40. [PMID: 30996642 DOI: 10.29390/cjrt-2018-005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
32 Steiropoulos P. Can we predict the survival of idiopathic pulmonary fibrosis patients? Sleep must be re-appreciated. J Clin Sleep Med 2013;9:603-4. [PMID: 23772194 DOI: 10.5664/jcsm.2760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Schiza SE, Bouloukaki I, Bolaki M, Antoniou KM. Obstructive sleep apnea in pulmonary fibrosis. Curr Opin Pulm Med 2020;26:443-8. [PMID: 32701670 DOI: 10.1097/MCP.0000000000000697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Pereira N, Cardoso A, Mota P, Santos A, Melo N, Morais A, Drummond M. Predictive factors of obstructive sleep apnoea in patients with fibrotic lung diseases. Sleep Medicine 2019;56:123-7. [DOI: 10.1016/j.sleep.2019.01.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Khor YH, Ryerson CJ, Landry SA, Howard ME, Churchward TJ, Edwards BA, Hamilton GS, Joosten SA. Interstitial lung disease and obstructive sleep apnea. Sleep Med Rev 2021;58:101442. [PMID: 33561604 DOI: 10.1016/j.smrv.2021.101442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Şahin Duyar S, Uzel Şener M, Akıncı Özyürek B, Fırat S, Kara T, Erdoğan Y, Kaya AG, Keyf İA. An Integrated Approach Toward the Clinical and Polysomnographic Characteristics of OSA Accompanying IPF. Turk Thorac J 2020;21:334-9. [PMID: 33031725 DOI: 10.5152/TurkThoracJ.2020.19002] [Reference Citation Analysis]
37 Alqalyoobi S, Fernández Pérez ER, Oldham JM. In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs. BMC Pulm Med 2020;20:289. [PMID: 33160338 DOI: 10.1186/s12890-020-01328-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Antoniou K, Kamekis A, Symvoulakis EK, Kokosi M, Swigris JJ. Burden of idiopathic pulmonary fibrosis on patients’ emotional well being and quality of life: a literature review. Current Opinion in Pulmonary Medicine 2020;26:457-63. [DOI: 10.1097/mcp.0000000000000703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
39 Ahmad K, Nathan SD. Novel management strategies for idiopathic pulmonary fibrosis. Expert Rev Respir Med 2018;12:831-42. [PMID: 30136607 DOI: 10.1080/17476348.2018.1513332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Tzouvelekis A, Voulgaris A, Steiropoulos P. Obstructive sleep apnea in patients with idiopathic pulmonary fibrosis: pulmonary hypertension could be the missing link for the diagnosis and different positive airway pressure treatment outcomes. J Clin Sleep Med 2021;17:1325. [PMID: 33682674 DOI: 10.5664/jcsm.9204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Tudorache V, Traila D, Marc M, Oancea C, Manolescu D, Tudorache E, Timar B, Albai A, Fira-Mladinescu O. Impact of moderate to severe obstructive sleep apnea on the cognition in idiopathic pulmonary fibrosis. PLoS One 2019;14:e0211455. [PMID: 30707735 DOI: 10.1371/journal.pone.0211455] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
42 King CS, Nathan SD. Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities. The Lancet Respiratory Medicine 2017;5:72-84. [DOI: 10.1016/s2213-2600(16)30222-3] [Cited by in Crossref: 81] [Cited by in F6Publishing: 39] [Article Influence: 16.2] [Reference Citation Analysis]
43 Khawaja AA, Chong DLW, Sahota J, Mikolasch TA, Pericleous C, Ripoll VM, Booth HL, Khan S, Rodriguez-Justo M, Giles IP, Porter JC. Identification of a Novel HIF-1α-αMβ2 Integrin-NET Axis in Fibrotic Interstitial Lung Disease. Front Immunol 2020;11:2190. [PMID: 33178179 DOI: 10.3389/fimmu.2020.02190] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Geng X, Dufu K, Hutchaleelaha A, Xu Q, Li Z, Li CM, Patel MP, Vlahakis N, Lehrer-Graiwer J, Oksenberg D. Increased hemoglobin-oxygen affinity ameliorates bleomycin-induced hypoxemia and pulmonary fibrosis. Physiol Rep 2016;4:e12965. [PMID: 27624688 DOI: 10.14814/phy2.12965] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
45 Papadogiannis G, Bouloukaki I, Mermigkis C, Michelakis S, Ermidou C, Mauroudi E, Moniaki V, Tzanakis N, Antoniou KM, Schiza SE. Patients with idiopathic pulmonary fibrosis with and without obstructive sleep apnea: differences in clinical characteristics, clinical outcomes, and the effect of PAP treatment. J Clin Sleep Med 2021;17:533-44. [PMID: 33108270 DOI: 10.5664/jcsm.8932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
46 Moua T, Lee AS, Ryu JH. Comparing effectiveness of prognostic tests in idiopathic pulmonary fibrosis. Expert Rev Respir Med 2019;13:993-1004. [PMID: 31405303 DOI: 10.1080/17476348.2019.1656069] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
47 Schertel A, Funke-Chambour M, Geiser T, Brill AK. Novel insights in cough and breathing patterns of patients with idiopathic pulmonary fibrosis performing repeated 24-hour-respiratory polygraphies. Respir Res 2017;18:190. [PMID: 29132424 DOI: 10.1186/s12931-017-0674-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
48 Adegunsoye A, Balachandran J. Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea. Mediators Inflamm 2015;2015:510105. [PMID: 25944985 DOI: 10.1155/2015/510105] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
49 Meyer KC, Danoff SK, Lancaster LH, Nathan SD. Management of Idiopathic Pulmonary Fibrosis in the Elderly Patient: Addressing Key Questions. Chest 2015;148:242-52. [PMID: 26149553 DOI: 10.1378/chest.14-2475] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
50 Abdel-Latif Thomasson D, Abou Taam R, Berteloot L, Khirani S, Griffon L, Hadchouel A, Delacourt C, Fauroux B. Sleep in children and young adults with interstitial and diffuse lung disease. Sleep Med 2021;80:23-9. [PMID: 33548566 DOI: 10.1016/j.sleep.2021.01.020] [Reference Citation Analysis]
51 Bosi M, Milioli G, Parrino L, Fanfulla F, Tomassetti S, Melpignano A, Trippi I, Vaudano AE, Ravaglia C, Mascetti S, Poletti V. Quality of life in idiopathic pulmonary fibrosis: The impact of sleep disordered breathing. Respiratory Medicine 2019;147:51-7. [DOI: 10.1016/j.rmed.2018.12.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
52 George PM, Patterson CM, Reed AK, Thillai M. Lung transplantation for idiopathic pulmonary fibrosis.Lancet Respir Med. 2019;7:271-282. [PMID: 30738856 DOI: 10.1016/S2213-2600(18)30502-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 24] [Article Influence: 17.3] [Reference Citation Analysis]
53 Schulz R, Heitmann J, Hirche TO. Schlafstörungen bei Lungenkrankheiten. Somnologie 2017;21:149-61. [DOI: 10.1007/s11818-017-0116-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
54 Munck C, Fry S, Lamblin C, Wallaert B, Chenivesse C. [Sleep disorders in idiopathic non-specific interstitial pneumonia]. Presse Med 2016:S0755-4982(16)30157-9. [PMID: 28029562 DOI: 10.1016/j.lpm.2016.06.010] [Reference Citation Analysis]
55 Yčas JW. Toward a Blood-Borne Biomarker of Chronic Hypoxemia: Red Cell Distribution Width and Respiratory Disease. Adv Clin Chem 2017;82:105-97. [PMID: 28939210 DOI: 10.1016/bs.acc.2017.06.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
56 Rodrigues MP, Vissoci CM, Rosa SP, Negreiros SBC. 24-Hour Hypoxia and Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis. Open Respir Med J 2017;11:10-6. [PMID: 28659997 DOI: 10.2174/1874306401711010010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
57 Konecny T, Kara T, Somers VK. Obstructive sleep apnea and hypertension: an update. Hypertension 2014;63:203-9. [PMID: 24379177 DOI: 10.1161/HYPERTENSIONAHA.113.00613] [Cited by in Crossref: 105] [Cited by in F6Publishing: 56] [Article Influence: 11.7] [Reference Citation Analysis]
58 Myall KJ, West A, Kent BD. Sleep and interstitial lung disease. Curr Opin Pulm Med 2019;25:623-8. [PMID: 31503213 DOI: 10.1097/MCP.0000000000000620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Betensley A, Sharif R, Karamichos D. A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis. J Clin Med 2016;6:E2. [PMID: 28035951 DOI: 10.3390/jcm6010002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
60 Randerath W, Verbraecken J, Andreas S, Arzt M, Bloch KE, Brack T, Buyse B, De Backer W, Eckert DJ, Grote L, Hagmeyer L, Hedner J, Jennum P, La Rovere MT, Miltz C, Mcnicholas WT, Montserrat J, Naughton M, Pepin J, Pevernagie D, Sanner B, Testelmans D, Tonia T, Vrijsen B, Wijkstra P, Levy P. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J 2017;49:1600959. [DOI: 10.1183/13993003.00959-2016] [Cited by in Crossref: 123] [Cited by in F6Publishing: 90] [Article Influence: 20.5] [Reference Citation Analysis]
61 Snow JB, Norton CE, Sands MA, Weise-Cross L, Yan S, Herbert LM, Sheak JR, Gonzalez Bosc LV, Walker BR, Kanagy NL, Jernigan NL, Resta TC. Intermittent Hypoxia Augments Pulmonary Vasoconstrictor Reactivity through PKCβ/Mitochondrial Oxidant Signaling. Am J Respir Cell Mol Biol 2020;62:732-46. [PMID: 32048876 DOI: 10.1165/rcmb.2019-0351OC] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Dudley KA, Malhotra A, Owens RL. Pulmonary Overlap Syndromes, with a focus on COPD and ILD. Sleep Med Clin 2014;9:365-79. [PMID: 26664352 DOI: 10.1016/j.jsmc.2014.05.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
63 Gonzalez-Garcia M, Rincon-Alvarez E, Alberti ML, Duran M, Caro F, Venero MDC, Liberato YE, Buendia-Roldan I. Comorbidities of Patients With Idiopathic Pulmonary Fibrosis in Four Latin American Countries. Are There Differences by Country and Altitude? Front Med (Lausanne) 2021;8:679487. [PMID: 34222287 DOI: 10.3389/fmed.2021.679487] [Reference Citation Analysis]
64 Troy LK, Corte TJ. Sleep disordered breathing in interstitial lung disease: A review. World J Clin Cases 2014; 2(12): 828-834 [PMID: 25516856 DOI: 10.12998/wjcc.v2.i12.828] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
65 Mermigkis C, Bouloukaki I, Antoniou K, Papadogiannis G, Giannarakis I, Varouchakis G, Siafakas N, Schiza SE. Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis. Sleep Breath 2015;19:385-91. [PMID: 25028171 DOI: 10.1007/s11325-014-1033-6] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 9.5] [Reference Citation Analysis]
66 Shmelev EI, Ergeshov AE, Gergert VY. [Differential diagnosis of idiopathic pulmonary fibrosis]. Ter Arkh 2020;92:102-8. [PMID: 32598801 DOI: 10.26442/00403660.2020.03.000346] [Reference Citation Analysis]
67 Adir Y, Humbert M, Chaouat A. Sleep-related breathing disorders and pulmonary hypertension. Eur Respir J 2021;57:2002258. [PMID: 32747397 DOI: 10.1183/13993003.02258-2020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Sergew A, Brown KK. Advances in the treatment of idiopathic pulmonary fibrosis. Expert Opin Emerg Drugs 2015;20:537-52. [PMID: 26629731 DOI: 10.1517/14728214.2015.1102886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
69 Fernández Fabrellas E, Peris Sánchez R, Sabater Abad C, Juan Samper G. Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis. Med Sci (Basel) 2018;6:E51. [PMID: 29904028 DOI: 10.3390/medsci6020051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
70 Liang J, Cade BE, He KY, Wang H, Lee J, Sofer T, Williams S, Li R, Chen H, Gottlieb DJ, Evans DS, Guo X, Gharib SA, Hale L, Hillman DR, Lutsey PL, Mukherjee S, Ochs-Balcom HM, Palmer LJ, Rhodes J, Purcell S, Patel SR, Saxena R, Stone KL, Tang W, Tranah GJ, Boerwinkle E, Lin X, Liu Y, Psaty BM, Vasan RS, Cho MH, Manichaikul A, Silverman EK, Barr RG, Rich SS, Rotter JI, Wilson JG, Redline S, Zhu X; NHLBI Trans-Omics for Precision Medicine (TOPMed)., TOPMed Sleep Working Group. Sequencing Analysis at 8p23 Identifies Multiple Rare Variants in DLC1 Associated with Sleep-Related Oxyhemoglobin Saturation Level. Am J Hum Genet 2019;105:1057-68. [PMID: 31668705 DOI: 10.1016/j.ajhg.2019.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
71 Puglisi S, Torrisi SE, Vindigni V, Giuliano R, Palmucci S, Mulè M, Vancheri C. New perspectives on management of idiopathic pulmonary fibrosis. Ther Adv Chronic Dis 2016;7:108-20. [PMID: 26977280 DOI: 10.1177/2040622315624276] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]